Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10676486
Macrocyclic RIP2 kinase inhibitors
granted -
US 10669242
Clostridium difficile toxin inhibitors
granted -
US 10668055
Cancer treatment using combinations of ERK and RAF inhibitors
granted -
US 10668049
Methods of treating cognitive decline with transforming growth factor beta inhibitors
granted -
US 10662183
Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription and methods for use of the same
granted -
US 10647715
KRas G12C inhibitors
granted -
US 10647711
Azepin-2-one derivatives as RSV inhibitors
granted -
US 10646577
mTORC1 inhibitors
granted -
US 10646475
SHMT inhibitors
granted -
US 10639289
Application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial infarction
granted -
US 10639302
Use of CDK9 inhibitors to reduce cartilage degradation
granted -
US 10640517
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted -
US 10640501
Methods of preparing inhibitors of influenza viruses replication
granted -
US 10640493
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
granted -
US 10633381
KRas G12C inhibitors
granted -
US 10633370
Phenyl indole allosteric inhibitors of p97 ATPase
granted -
US 10632209
ASH1L inhibitors and methods of treatment therewith
granted -
US 10633345
Human plasma kallikrein inhibitors
granted -
US 10626087
Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same
granted -
US 10626129
Heteroaryl inhibitors of PDE4
granted -
US 10626094
Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof
granted -
US 10617737
Compositions for treating heart disease by inhibiting the action of mAKAP-β
granted -
US 10610563
Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2
granted -
US 10611758
N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
granted